Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifabutin PK and Safety in HIV/TB Co-infected Patients
NCT02415985Phase 2Completed
- Sponsor
- HIV-NAT
- Start
- Jun 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifabutin in Tuberculosis (TB), sponsored by HIV-NAT. Started Jun 2015; status: completed.
02
Drugs
rifabutin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02415985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415985.